Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K23 AI120761)
Received: 28 October 2018
Accepted: 15 February 2019
First Online: 15 March 2019
Ethics approval and consent to participate
: Study procedures were approved by the University of Washington Institutional Review Board and the Senegal Comité National d’Ethique pour la Recherche en Santé (CNERS). Written informed consent was required for participation in this study. For subjects < 18 years of age, consent to participate was obtained from their legal guardian.
: Not applicable
: GSG has received research grants and support from the US National Institutes of Health, University of Washington, Bill & Melinda Gates Foundation, Gilead Sciences, Alere Technologies, Merck & Co, Inc, Janssen Pharmaceutica, Cerus Corporation, ViiV Healthcare, Bristol-Myers Squibb, and Abbott Molecular Diagnostics. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.